Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance

Amotosalen and ultraviolet A (UVA) photochemical-based pathogen reduction using the Intercept™ Blood System (IBS) is an effective and established technology for platelet and plasma components, which is adopted in more than 40 countries worldwide. Several reports point towards a reduced platelet func...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Haematologica
Egile Nagusiak: Stivala, Simona, Gobbato, Sara, Infanti, Laura, Reiner, Martin F., Bonetti, Nicole, Meyer, Sara C., Camici, Giovanni G., Lüscher, Thomas F., Buser, Andreas, Beer, Jürg H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5622849/
https://ncbi.nlm.nih.gov/pubmed/28729303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.164137
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak